The biologic drug Enbrel has gotten the green light from an FDA advisory committee to treat moderate to severe plaque psoriasis in children and teens who have tried other psoriasis treatments. The FDA ...

Eight months after bowing to FDA pressure to pull the original spot, Amgen has launched a revamped television ad for Enbrel (etanercept) that it says better explains the product’s psoriasis indication ...

Please provide your email address to receive an email when new articles are posted on . Amgen announced in a press release that the FDA has accepted to review its supplemental biologics license ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Amgen’s supplemental biologics license application for expanded use of Enbrel for treating ...

Novartis’s Sandoz is aiming to bring a biosimilar of Amgen anti-TNF giant, Enbrel, to market. And it just rolled out efficacy data that could help it get there. Thursday, the generics behemoth ...

Amgen Inc. won U.S. approval Friday to market its rheumatoid arthritis drug Enbrel as a treatment for the skin disorder psoriasis. A Food and Drug Administration spokeswoman said Enbrel had been ...

THOUSAND OAKS, Calif. and COLLEGEVILLE, Pa., Feb. 4, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) and Pfizer Inc. (NYSE: PFE) today announced results from a new trial that demonstrated Enbrel® ...

Washington DC - Etanercept (Enbrel¿, Amgen/Wyeth) has been approved by the US FDA for use in the treatment of psoriasis. It becomes the first of the TNF antagonists to have this indication, although ...

THOUSAND OAKS, Calif., and COLLEGEVILLE, Pa., April 30, 2004 – Amgen (N), today announced that Enbrel® (etanercept) has been approved by the U.S. Food and Drug Ad ASDAQ: AMGN) and Wyeth ...